Thermo Fisher Scientific Inc.
TMO
$402.82
-$0.93-0.23%
NYSE
| 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.18% | 4.68% | 0.23% | -1.37% | -3.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.18% | 4.68% | 0.23% | -1.37% | -3.41% |
| Cost of Revenue | -0.11% | 1.24% | 0.27% | -3.51% | -6.19% |
| Gross Profit | 0.62% | 9.72% | 0.16% | 1.85% | 0.93% |
| SG&A Expenses | -4.62% | 3.96% | 2.06% | 1.68% | 2.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 2,900.00% | -- | -- | -- |
| Total Operating Expenses | -1.11% | 2.69% | 1.00% | -2.19% | -4.07% |
| Operating Income | 6.67% | 13.56% | -3.14% | 2.75% | 0.06% |
| Income Before Tax | -0.43% | 13.51% | -1.09% | 18.95% | 20.55% |
| Income Tax Expenses | -66.19% | 12.78% | 86.79% | 146.15% | 510.87% |
| Earnings from Continuing Operations | 13.44% | 13.57% | -3.83% | 14.10% | 3.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00% | -75.00% | -- | -500.00% | -33.33% |
| Net Income | 13.48% | 12.27% | -4.96% | 13.74% | 3.03% |
| EBIT | 6.67% | 13.56% | -3.14% | 2.75% | 0.06% |
| EBITDA | -0.62% | 6.29% | -6.40% | -0.57% | -0.85% |
| EPS Basic | 14.68% | 13.74% | -3.96% | 14.93% | 4.10% |
| Normalized Basic EPS | 4.90% | 16.60% | -2.88% | 5.23% | 8.96% |
| EPS Diluted | 15.03% | 13.81% | -3.85% | 15.10% | 4.22% |
| Normalized Diluted EPS | 5.17% | 16.60% | -2.88% | 5.50% | 8.95% |
| Average Basic Shares Outstanding | -1.05% | -1.29% | -1.04% | -1.04% | -1.04% |
| Average Diluted Shares Outstanding | -1.30% | -1.29% | -1.03% | -1.29% | -1.03% |
| Dividend Per Share | 10.26% | 11.43% | 11.43% | 11.43% | 11.43% |
| Payout Ratio | -0.03% | -0.02% | 0.17% | -0.03% | 0.12% |